Literature DB >> 6300233

Immunologic and ionophore-induced generation of leukotriene B4 from mouse bone marrow-derived mast cells.

J M Mencia-Huerta, E Razin, E W Ringel, E J Corey, D Hoover, K F Austen, R A Lewis.   

Abstract

Mouse bone marrow-derived mast cells differentiated in vitro and sensitized with monoclonal IgE respond to antigen-initiated activation-secretion with the generation of leukotriene B4 (LTB4), a highly potent chemotactic factor. The antigen-initiated net percent release of the secretory granule marker beta-hexosaminidase and the generation of immunoreactive LTB4 and of immunoreactive leukotriene C4 (LTC4) were not diminished by washing the cells before challenge, indicating that interaction of the antigen occurred with the IgE fixed on cell membranes and was not due to phagocytosis of immune complexes formed in the fluid phase. The parallel dose-response relationship for the antigen-induced release of the performed mediator and the generation of both leukotrienes along with the superimposable time courses of their extracellular appearance indicate the origin of these mediators from a common cell type with IgE receptors. Resolution by reverse phase-high performance liquid chromatography (RP-HPLC) of the leukotrienes released from unsensitized cells by ionophore A23187 and from sensitized cells by the specific antigen revealed that the generation of LTB4 was accompanied by the production of the two diastereoisomers of 6-trans-LTB4, which were not immunoreactive. The immunoreactive LTB4 eluted from RP-HPLC at the same retention time as synthetic LTB4 was present in similar nanogram quantities when measured by either radioimmunoassay or integrated absorbance at 269 nm and exhibited a chemotactic activity for human neutrophils on a weight basis comparable to that of synthetic LTB4. The overall recoveries after RP-HPLC of immunoreactive LTB4 released from ionophore A23187-activated, bone marrow-derived mast cells and of added tritiated synthetic LTB4 in separate experiments with ionophore-activated cells were comparable and greater than 78%. The maximum generation of LTB4 by ionophore A23187-activated cells of 7.9 +/- 2.5 ng/10(6) cells (mean +/- SD), occurring at 40 min, was greater than the maximum generation of 4.5 +/- 0.8 ng/10(6) cells, with immunologic stimulation occurring 5 min after antigen challenge of sensitized cells. The initial rate of LTB4 generation after perturbation of the IgE-Fc receptors, however, exceeded that following ionophore A23187 stimulation and may represent one important variable in establishing a significant chemotactic gradient.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6300233

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Deficient eosinophil chemotaxis-promoting activity of genetically normal mast cells transplanted into subcutaneous tissue of Mitfmi-vga9/Mitfmi-vga9 mice: comparison of the activity and mast cell distribution pattern with KitW/KitW-vMice.

Authors:  Keisuke Oboki; Eiichi Morii; Yukihiko Kitamura
Journal:  Am J Pathol       Date:  2004-10       Impact factor: 4.307

Review 2.  Mast cell modulation of the vascular and lymphatic endothelium.

Authors:  Christian A Kunder; Ashley L St John; Soman N Abraham
Journal:  Blood       Date:  2011-09-08       Impact factor: 22.113

3.  Cultured human bone marrow-derived mast cells, their similarities to cultured murine E-mast cells.

Authors:  L Gilead; E Rahamim; I Ziv; R Or; E Razin
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

Review 4.  Mast cell heterogeneity: evidence and implications.

Authors:  K E Barrett; D D Metcalfe
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

Review 5.  The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology.

Authors:  R A Lewis; K F Austen
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

6.  Lung responsiveness to antigen in sensitised mice of different strains.

Authors:  C Zuany-Amorim; M Pretolani; D Leduc; R Cordeiro; B B Vargaftig
Journal:  Agents Actions       Date:  1993

7.  The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2.

Authors:  H Z Movat; C Rettl; C E Burrowes; M G Johnston
Journal:  Am J Pathol       Date:  1984-05       Impact factor: 4.307

8.  Leukotriene B4 action on endothelium mediates augmented neutrophil/endothelial adhesion.

Authors:  R L Hoover; M J Karnovsky; K F Austen; E J Corey; R A Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

9.  Increased synthesis of leukotrienes in the mouse model of diabetic retinopathy.

Authors:  Ramaprasad Talahalli; Simona Zarini; Nader Sheibani; Robert C Murphy; Rose A Gubitosi-Klug
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-15       Impact factor: 4.799

10.  Characterization and pharmacological modulation of antigen-induced peritonitis in actively sensitized mice.

Authors:  C Zuany-Amorim; D Leduc; B B Vargaftig; M Pretolani
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.